We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$400B
AUM Growth
+$29.4B
Cap. Flow
+$10.8B
Cap. Flow %
2.7%
Top 10 Hldgs %
14.74%
Holding
7,051
New
207
Increased
2,867
Reduced
3,206
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Healthcare 9.53%
3 Financials 9.25%
4 Consumer Discretionary 7.98%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PW
6376
Power REIT
PW
$2.81M
$2K ﹤0.01%
28
-65
-70% -$3.94K
RVP icon
6377
Retractable Technologies
RVP
$19.8M
$2K ﹤0.01%
+2,500
New +$1.89K
DCOY
6378
Decoy Therapeutics
DCOY
$2.31M
0
SNFCA icon
6379
Security National Financial
SNFCA
$253M
$2K ﹤0.01%
+439
New +$1.52K
UTSI icon
6380
UTStarcom
UTSI
$23.5M
$2K ﹤0.01%
125
VXRT
6381
DELISTED
Vaxart
VXRT
$2K ﹤0.01%
751
-5
-0.7% -$15
RDGT
6382
Ridgetech Inc
RDGT
$2.77M
0
DXYN
6383
DELISTED
Dixie Group Inc
DXYN
$2K ﹤0.01%
1,558
+1,258
+419% +$2.46K
GENE
6384
DELISTED
Genetic Technologies Ltd.
GENE
$2K ﹤0.01%
76
PRVB
6385
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2K ﹤0.01%
+534
New +$2.11K
OIG
6386
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2K ﹤0.01%
25
GRU
6387
DELISTED
ELEMENTS Linked to the ICE BofAML Commodity Index eXtra Grains Total Return
GRU
$2K ﹤0.01%
700
+400
+133% +$1.36K
IEHS
6388
DELISTED
iShares Evolved U.S. Healthcare Staples ETF
IEHS
$2K ﹤0.01%
+60
New +$1.69K
IEME
6389
DELISTED
iShares Evolved U.S. Media and Entertainment ETF
IEME
$2K ﹤0.01%
75
+45
+150% +$1.22K
SQBG
6390
DELISTED
Sequential Brands Group, Inc.
SQBG
$2K ﹤0.01%
27
-3,125
-99% -$242K
LONE
6391
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$2K ﹤0.01%
274
-21,702
-99% -$190K
SITO
6392
DELISTED
SITO MOBILE, LTD
SITO
$2K ﹤0.01%
1,100
-4,000
-78% -$8.35K
MNI
6393
DELISTED
The McClatchy Company Class A Common Stock
MNI
$2K ﹤0.01%
185
IDXG
6394
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$2K ﹤0.01%
107
+62
+138% +$747
PTX
6395
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$2K ﹤0.01%
2,071
-1,240
-37% -$2.08K
CELGZ
6396
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$2K ﹤0.01%
1,464
-900
-38% -$1.2K
CYTR
6397
DELISTED
CytRx Corp
CYTR
$2K ﹤0.01%
2,744
-1,104
-29% -$1.25K
ADIL
6398
Adial Pharmaceuticals
ADIL
$7.97M
$1K ﹤0.01%
+1
New +$2.08K
AKTX
6399
Akari Therapeutics
AKTX
$12.9M
0
ATOM icon
6400
Atomera
ATOM
$205M
$1K ﹤0.01%
200

Similar funds

Morgan Stanley's Q3 2018 Portfolio in Review

As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
  • Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
  • Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
  • Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
  • Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
  • Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.